376 related articles for article (PubMed ID: 16567033)
1. Calcium channel blockers for tocolysis: a review of their role and safety following reports of serious adverse events.
Oei SG
Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):137-45. PubMed ID: 16567033
[TBL] [Abstract][Full Text] [Related]
2. Calcium channel blockers for the management of preterm birth: a review.
Nassar AH; Aoun J; Usta IM
Am J Perinatol; 2011 Jan; 28(1):57-66. PubMed ID: 20640972
[TBL] [Abstract][Full Text] [Related]
3. [Nifedipine first choice in management of threatening preterm labor].
Papatsonis DN; Timmerman CC; Oei SG; van Geijn HP
Ned Tijdschr Geneeskd; 2002 Oct; 146(42):1980-3. PubMed ID: 12420423
[TBL] [Abstract][Full Text] [Related]
4. [Calcium channel blockers pharmacology and their use as tocolytics].
Bejan-Angoulvant T; Crochet J; Jonville-Bera AP
J Gynecol Obstet Biol Reprod (Paris); 2015 Apr; 44(4):305-11. PubMed ID: 25728783
[TBL] [Abstract][Full Text] [Related]
5. 'Normal' pregnancy with adverse events on initial tocolytic treatment.
Dudenhausen J
BJOG; 2006 Dec; 113 Suppl 3():116-7. PubMed ID: 17206979
[TBL] [Abstract][Full Text] [Related]
6. [Tocolysis with calcium-channel-blockers].
Tsatsaris V; Carbonne B
J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):246-51. PubMed ID: 11398000
[TBL] [Abstract][Full Text] [Related]
7. Adverse effects of tocolytic therapy.
Caritis S
BJOG; 2005 Mar; 112 Suppl 1():74-8. PubMed ID: 15715600
[TBL] [Abstract][Full Text] [Related]
8. [Adverse effects of calcium channels blockers used as tocolytic treatment].
Clouqueur E; Gautier S; Vaast P; Coulon C; Deruelle P; Subtil D; Debarge V
J Gynecol Obstet Biol Reprod (Paris); 2015 Apr; 44(4):341-56. PubMed ID: 25726253
[TBL] [Abstract][Full Text] [Related]
9. Tocolytic effectiveness of nifedipine versus ritodrine and follow-up of newborns: a randomised controlled trial.
Van De Water M; Kessel ET; De Kleine MJ; Oei SG
Acta Obstet Gynecol Scand; 2008; 87(3):340-5. PubMed ID: 18307075
[TBL] [Abstract][Full Text] [Related]
10. [Which tocolytic drugs in case of preterm labor?].
Carbonne B; Tsatsaris V
J Gynecol Obstet Biol Reprod (Paris); 2002 Nov; 31(7 Suppl):5S96-104. PubMed ID: 12454631
[TBL] [Abstract][Full Text] [Related]
11. Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers.
Kim A; Shim JY
BJOG; 2006 Dec; 113 Suppl 3():113-5. PubMed ID: 17206978
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of preterm delivery with calcium channel blockers--Nifedipine].
Nikolov A; Markov D; Dimitrov A; Ivanov S; Diavolov V
Akush Ginekol (Sofiia); 2007; 46(9):18-22. PubMed ID: 18642559
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the rate of maternal complications of nifedipine and nicardipine in cases of preterm labor: historical study on two consecutive periods].
Laas E; Deis S; Haddad B; Kayem G
J Gynecol Obstet Biol Reprod (Paris); 2012 Nov; 41(7):631-7. PubMed ID: 22771075
[TBL] [Abstract][Full Text] [Related]
14. Preterm labour management--an evidence--update.
Piyamongkol W
J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S154-7. PubMed ID: 21213513
[TBL] [Abstract][Full Text] [Related]
15. The quality of randomised trials of tocolysis.
Thornton JG
BJOG; 2006 Dec; 113 Suppl 3():93-5. PubMed ID: 17206973
[TBL] [Abstract][Full Text] [Related]
16. Maintenance tocolysis.
Thornton JG
BJOG; 2005 Mar; 112 Suppl 1():118-21. PubMed ID: 15715609
[TBL] [Abstract][Full Text] [Related]
17. Atosiban versus usual care for the management of preterm labor.
Husslein P; Cabero Roura L; Dudenhausen JW; Helmer H; Frydman R; Rizzo N; Schneider D
J Perinat Med; 2007; 35(4):305-13. PubMed ID: 17614750
[TBL] [Abstract][Full Text] [Related]
18. [Nifedipine or nicardipine in management of threatened preterm delivery: an observational population-based study].
Le Ray C; Maillard F; Carbonne B; Verspyck E; Cabrol D; Goffinet F;
J Gynecol Obstet Biol Reprod (Paris); 2010 Oct; 39(6):490-7. PubMed ID: 20627613
[TBL] [Abstract][Full Text] [Related]
19. [Tocolysis with nifedipin; its use in current practice].
Karamisheva V; Ivanov S; Jordanova D; Marinov B; Dimitrov G; Nachev A
Akush Ginekol (Sofiia); 2014; 53 Suppl 1():8-12. PubMed ID: 25510034
[TBL] [Abstract][Full Text] [Related]
20. The occurrence of adverse events in women receiving continuous subcutaneous terbutaline therapy.
Elliott JP; Istwan NB; Rhea D; Stanziano G
Am J Obstet Gynecol; 2004 Oct; 191(4):1277-82. PubMed ID: 15507953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
